应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
NVO 诺和诺德
盘前交易 04-10 06:20:30 EDT
37.44
-0.17
-0.45%
盘前
38.32
+0.88
+2.35%
06:19 EDT
最高
37.65
最低
36.82
成交量
1,123万
今开
37.18
昨收
37.61
日振幅
2.21%
总市值
1,662亿
流通市值
1,194亿
总股本
44.39亿
成交额
4.18亿
换手率
0.35%
流通股本
31.88亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
礼来Foundayo登陆美国零售药店 与诺和诺德争夺减肥药市场
金吾财讯 · 04-09 20:21
礼来Foundayo登陆美国零售药店 与诺和诺德争夺减肥药市场
司美格鲁肽仿制药冲击印度市场 礼来(LLY)份额遭显著挤压
金吾财讯 · 04-09 18:13
司美格鲁肽仿制药冲击印度市场 礼来(LLY)份额遭显著挤压
巨头之战：礼来口服减肥药获批 诺和诺德抛出数据回应
21世纪经济报道 · 04-08 07:00
巨头之战：礼来口服减肥药获批 诺和诺德抛出数据回应
诺和诺德推出399美元Wegovy HD 比礼来竞品便宜约40%
环球市场播报 · 04-08 03:32
诺和诺德推出399美元Wegovy HD 比礼来竞品便宜约40%
剂量翻三倍、月费仅涨50美元：诺和诺德(NVO.US)推高剂量Wegovy硬刚礼来(LLY.US)Zepbound
智通财经 · 04-07 21:30
剂量翻三倍、月费仅涨50美元：诺和诺德(NVO.US)推高剂量Wegovy硬刚礼来(LLY.US)Zepbound
诺和诺德首席执行官Mike Doustdar：减肥药需求远超行业目前所能提供的规模。
格隆汇 · 04-06
诺和诺德首席执行官Mike Doustdar：减肥药需求远超行业目前所能提供的规模。
诺和诺德：减肥药热潮远未达到顶峰
环球市场播报 · 04-06
诺和诺德：减肥药热潮远未达到顶峰
司美格鲁肽口服减重药已开出超60万张处方 诺和诺德CEO：减重药市场目前仅触及“皮毛”
格隆汇 · 04-06
司美格鲁肽口服减重药已开出超60万张处方 诺和诺德CEO：减重药市场目前仅触及“皮毛”
司美格鲁肽口服减重药已开出超60万张处方，市场空间还有多大
第一财经 · 04-06
司美格鲁肽口服减重药已开出超60万张处方，市场空间还有多大
巨头之战：礼来口服减肥药获批，诺和诺德抛出数据回应
21世纪经济报道 · 04-03
巨头之战：礼来口服减肥药获批，诺和诺德抛出数据回应
诺和诺德：Wegovy口服片剂表现优于礼来的口服GLP-1药物
格隆汇 · 04-02
诺和诺德：Wegovy口服片剂表现优于礼来的口服GLP-1药物
诺和诺德称：口服版Wegovy减肥效果优于礼来GLP‑1口服药
环球市场播报 · 04-02
诺和诺德称：口服版Wegovy减肥效果优于礼来GLP‑1口服药
消息称特朗普拟对部分制药企业征收新关税
老虎资讯综合 · 04-02
消息称特朗普拟对部分制药企业征收新关税
礼来口服减肥药获批 加剧与诺和诺德竞争
格隆汇 · 04-01
礼来口服减肥药获批 加剧与诺和诺德竞争
诺和诺德(NVO)推出Wegovy折扣订阅计划 旨在降价抢攻减肥药市场
金吾财讯 · 03-31
诺和诺德(NVO)推出Wegovy折扣订阅计划 旨在降价抢攻减肥药市场
诺和诺德：Wegovy订阅计划将于3月31日起通过Ro、WeightWatchers和LifeMD提供
美股速递 · 03-31
诺和诺德：Wegovy订阅计划将于3月31日起通过Ro、WeightWatchers和LifeMD提供
诺和诺德：Wegovy口服药9毫克及25毫克剂量推出订阅计划，3个月套餐每月289美元、6个月套餐每月269美元、12个月套餐每月249美元
美股速递 · 03-31
诺和诺德：Wegovy口服药9毫克及25毫克剂量推出订阅计划，3个月套餐每月289美元、6个月套餐每月269美元、12个月套餐每月249美元
诺和诺德每周一次基础胰岛素制剂Awiqli获美国FDA批准
格隆汇 · 03-28
诺和诺德每周一次基础胰岛素制剂Awiqli获美国FDA批准
诺和诺德“周制剂”胰岛素获美国FDA批准上市
金吾财讯 · 03-27
诺和诺德“周制剂”胰岛素获美国FDA批准上市
美股异动丨诺和诺德盘前涨超2%，“周制剂”胰岛素在美获批上市
格隆汇 · 03-27
美股异动丨诺和诺德盘前涨超2%，“周制剂”胰岛素在美获批上市
加载更多
公司概况
公司名称：
诺和诺德
所属市场：
NYSE
上市日期：
--
主营业务：
Novo Nordisk A/S成立于1989年，由两家丹麦公司Nordisk Gentofte A/S和Novo Industri A/S合并而成。该公司是一家全球性的医疗保健公司，也是肥胖和糖尿病护理、制造和营销包括GLP-1受体激动剂和现代胰岛素在内的医药产品的世界领先企业。总部位于丹麦，业务遍及约80个国家，产品销往约170个国家。
发行价格：
--
{"stockData":{"symbol":"NVO","market":"US","secType":"STK","nameCN":"诺和诺德","latestPrice":37.44,"timestamp":1775764800000,"preClose":37.61,"halted":0,"volume":11231168,"hourTrading":{"tag":"盘前","latestPrice":38.3184,"preClose":37.44,"latestTime":"06:19 EDT","volume":104533,"amount":3981390.1842,"timestamp":1775816390269,"change":0.8784,"changeRate":0.023462,"amplitude":0.015224},"delay":0,"changeRate":-0.004520074448285076,"floatShares":3187922885,"shares":4439052849,"eps":3.620568,"marketStatus":"盘前交易","change":-0.17,"latestTime":"04-10 06:20:30 EDT","open":37.18,"high":37.65,"low":36.82,"amount":418412446.74943995,"amplitude":0.022069,"askPrice":38.31,"askSize":150,"bidPrice":38.29,"bidSize":671,"shortable":3,"etf":0,"ttmEps":3.620568,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775827800000},"marketStatusCode":1,"adr":1,"adrRate":1,"listingDate":363499200000,"exchange":"NYSE","adjPreClose":37.44,"dividendRate":0.045992,"preHourTrading":{"tag":"盘前","latestPrice":38.3184,"preClose":37.44,"latestTime":"06:19 EDT","volume":104533,"amount":3981390.1842,"timestamp":1775816390269,"change":0.8784,"changeRate":0.023462,"amplitude":0.015224},"postHourTrading":{"tag":"盘后","latestPrice":37.42,"preClose":37.44,"latestTime":"19:58 EDT","volume":654986,"amount":24523789.5004,"timestamp":1775779083101,"change":-0.02,"changeRate":-0.000534,"amplitude":0.002671},"volumeRatio":0.7188662171788499,"optionData":{"bulkOrders":[{"symbol":"NVO","call":false,"expireDate":1777003200000,"strike":"35.5","timestamp":1775752233780,"price":0.55,"volume":4500,"amount":247500,"type":"+"},{"symbol":"NVO","call":false,"expireDate":1776398400000,"strike":"45.0","timestamp":1775763623314,"price":7.6,"volume":2850,"amount":2166000,"type":"-"}]},"impliedVol":0.5505,"impliedVolPercentile":0.7108},"requestUrl":"/m/hq/s/NVO","defaultTab":"news","newsList":[{"id":"2626869182","title":"礼来Foundayo登陆美国零售药店 与诺和诺德争夺减肥药市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2626869182","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626869182?lang=zh_cn&edition=full","pubTime":"2026-04-09 20:21","pubTimestamp":1775737303,"startTime":"0","endTime":"0","summary":"金吾财讯 | 礼来公司(LLY)周四宣布，其新获批的减肥药Foundayo(奥福格列隆)即日起正式登陆美国零售药店，进一步扩大供应范围，与诺和诺德(NVO)展开正面竞争。本月初，FDA批准该药物用于肥胖或超重成年人的每日一次治疗，礼来随即通过自有网站接受处方，后拓展至远程医疗提供商，如今完成零售药店布局。其最低剂量月用量对现金支付顾客定价为每月149美元。作为全球第二款获批的口服GLP-1减肥药，Foundayo的上市将加剧礼来与诺和诺德的市场争夺。诺和诺德今年1月推出口服Wegovy后，已推出多月订阅计划，为自费患者提供折扣，巩固市场地位。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"298983","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2746668974.SGD","SGXZ51526630.SGD","IE00B4JS1V06.HKD","SG9999001176.SGD","LU2552382215.SGD","LU2462157665.USD","IE00BKPKM429.USD","SGXZ31699556.SGD","LU2237443895.HKD","LU1814569148.SGD","LU0323591593.USD","LU1145028129.USD","LU2168564495.EUR","LU2491050154.USD","LU0889565916.HKD","SG9999015978.USD","LU1061106388.HKD","LU2111349929.HKD","SGXZ57979304.SGD","LU0882574055.USD","LU0672654240.SGD","LU2063271972.USD","SG9999014914.USD","LU2028103732.USD","IE00BK4W5M84.HKD","LU2237443465.HKD","LU1551013342.USD","LU1868836591.USD","LU2265009873.SGD","IE00B4R5TH58.HKD","LU1093756325.SGD","SG9999014898.SGD","IE00B1XK9C88.USD","LU2896262040.SGD","SGXZ99366536.SGD","IE00BKDWB100.SGD","LU2108987350.USD","LU2750360997.AUD","LU0114720955.EUR","LU0154236417.USD","LU0061475181.USD","SG9999014880.SGD","LU0096364046.USD","LU0823416689.USD","IE00BFSS7M15.SGD","LU2237443622.USD","IE00BJJMRZ35.SGD","LU0158827781.USD","LU0234572021.USD","LU1057294990.SGD","LU2361044865.SGD","LU2552382132.HKD","BK4599","LU2168563687.JPY","LU2471134952.CNY","LU2211815571.USD","LU2746668461.USD","IE0004445015.USD","LU0820561818.USD","LU0882574139.USD","IE00BJJMRX11.SGD","LU0786609619.USD","LU2023250330.USD","LU2417539215.USD","LU2168564065.EUR","SG9999001176.USD","LU1366192091.USD","LU1868837136.USD","LU0094547139.USD","LU0158827948.USD","LU0225283273.USD","BK4581","LU0203201768.USD","LU1064131342.USD","LU2087625088.SGD","IE00BFSS8Q28.SGD","LU2112291526.USD","NVOX","LU1551013425.SGD","LU1720051108.HKD","LU2324357040.USD","LU2237443549.SGD","LU0471298694.HKD","NVO","LU1629891620.HKD","LU2750360641.GBP","LU1035775433.USD","LU2089283258.USD","IE00B1BXHZ80.USD","LU0640476718.USD","LU2361044949.HKD","LU1988902786.USD","LU2471134879.HKD","LU1267930730.SGD","NVOH","SG9999013999.USD","LU0198837287.USD","LU0689472784.USD","LU0320765059.SGD","LU2023250504.SGD","BK4007","LU0820562030.AUD","ELIL","IE0001KFT4U8.USD","LU1623119135.USD","LU0353189763.USD","LU2360106947.USD","LU0943347566.SGD","LU0417517546.SGD","LU1232071149.USD","BK4532","LU2023251221.USD","LU2271345857.HKD","LU2468319806.SGD","LU1804176565.USD","LU2089284900.SGD","LU2756315664.SGD","LU2106854487.HKD","LU2456880835.USD","LU0471298777.SGD","LU2237443978.SGD","ELIS","IE00BK4W5L77.USD","LU0256863902.USD","LU0432979614.USD","LU2602419157.SGD","LU2491050071.SGD","LU2357305700.SGD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU2168564222.USD","GB00BDT5M118.USD","BK4585","LU2213496289.HKD","LU0787776722.HKD","LU1291159041.SGD","LLYX","LU1868836914.USD","IE00BZ1G4Q59.USD","LU0683600562.USD","IE00BWXC8680.SGD","SG9999015986.USD","LU0203202063.USD","LU2264538146.SGD","LU1093756168.USD","SG9999018865.SGD","IE0002141913.USD","LU0210536198.USD","LU0266013472.USD","IE00BN29S564.USD","LU2168564149.EUR","LU0316494557.USD","LU2361045086.USD","LU1983299246.USD","LLII","LU2089984988.USD","LU0354030511.USD","SG9999014906.USD","IE00B775H168.HKD","LU2461242641.AUD","IE00BJJMRY28.SGD","LU0820561909.HKD","LU0238689110.USD","IE00BJLML261.HKD","LU0289739699.SGD","LU0385154629.USD","LU0456855351.SGD","LU0256863811.USD","LU1712237335.SGD","LU0097036916.USD","LU2237443382.USD","SG9999015952.SGD","LU0058720904.USD","IE0005OL40V9.USD","LU0354030438.USD","LU1868836757.USD","LU2236285917.USD","LLY","LU2471134523.USD","SGXZ81514606.USD","LU1069344957.HKD","LU0823434740.USD","SG9999017495.SGD","LU0823434583.USD","SG9999018857.SGD","LU1280957306.USD","LU1917777945.USD","LU0006306889.USD","LU0106261372.USD","LU2756315318.SGD","LU1548497426.USD","BK4516","LU0353189680.USD","LU0109394709.USD","LU2552382058.USD","LU1868837300.USD","SG9999015945.SGD","BK4534","LU0466842654.USD","IE00BKVL7J92.USD","LU0109391861.USD","LU2237438978.USD","LU2491049909.HKD","LU1323610961.USD","LU1989771016.USD","LU0320765992.SGD","LU1720051017.SGD","LU2471134796.USD","LU0708995401.HKD","IE0004445239.USD","IE00B2B36J28.USD","LLYZ","LU0079474960.USD","LU0964807845.USD","BK4533","LU0122379950.USD","LU1974910355.USD","IE0009355771.USD","IE00B7KXQ091.USD","LU1023059063.AUD","BK4588","LU1127390331.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626818345","title":"司美格鲁肽仿制药冲击印度市场 礼来(LLY)份额遭显著挤压","url":"https://stock-news.laohu8.com/highlight/detail?id=2626818345","media":"金吾财讯","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626818345?lang=zh_cn&edition=full","pubTime":"2026-04-09 18:13","pubTimestamp":1775729624,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺和诺德(NVO)司美格鲁肽低价仿制药在印度上市，迅速改变当地肥胖症药物市场格局，挤压礼来(LLY)替尔泊肽份额，也为全球专利到期后的市场走向提供参考。数据显示，司美格鲁肽在印度GLP-1市场份额从25%升至33%，替尔泊肽则由71%降至64%，对应销售额明显下滑。本土药企Torrent跻身仿制药头部企业，占据8%市场份额。有分析指出，当前印度市场仿制药需求爆发，价格竞争激烈，成为观察专利到期后品牌药优势削弱的典型样本，礼来后续也将在全球面临同类冲击。","market":"other","thumbnail":"https://static.szfiu.com/news/20210810/ZDhjMmEyODE0Mjk1MzY2MjA4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZDhjMmEyODE0Mjk1MzY2MjA4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"298970","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0786609619.USD","ELIS","IE0009355771.USD","SG9999001176.SGD","LU0471298777.SGD","LU0882574055.USD","LU2237443895.HKD","IE0005OL40V9.USD","SG9999001176.USD","SGXZ81514606.USD","SG9999014906.USD","IE0004445015.USD","LU2168564149.EUR","LU2028103732.USD","LU0820561909.HKD","LU0158827781.USD","LU1551013425.SGD","BK4557","SG9999014914.USD","IE00BKPKM429.USD","LU2211815571.USD","LU2491050154.USD","LU1983299246.USD","LU2111349929.HKD","LU2468319806.SGD","LU2471134952.CNY","LU2106854487.HKD","LU0466842654.USD","LU0058720904.USD","LU0354030511.USD","LU2264538146.SGD","LU1814569148.SGD","LU1712237335.SGD","LU1093756168.USD","LU1868836914.USD","LU2456880835.USD","LU2168563687.JPY","LU2552382132.HKD","LU2023250504.SGD","LU0097036916.USD","LU0683600562.USD","LU0432979614.USD","LU0061475181.USD","LU0456855351.SGD","LU0471298694.HKD","BK4534","LU1280957306.USD","LU1974910355.USD","LU1804176565.USD","LU0672654240.SGD","LU2265009873.SGD","LU2112291526.USD","LU2237443622.USD","IE00B1XK9C88.USD","SG9999014898.SGD","LU0266013472.USD","LU2108987350.USD","LU0640476718.USD","LU0079474960.USD","LU1989771016.USD","LU2552382058.USD","IE00B775H168.HKD","ELIL","SG9999015952.SGD","BK4533","LU0417517546.SGD","LU0823434740.USD","LU0689472784.USD","IE0002141913.USD","LU0820561818.USD","IE00BZ1G4Q59.USD","LU2089984988.USD","LU2023250330.USD","IE00B4JS1V06.HKD","LU2750360997.AUD","LU1232071149.USD","IE00B7KXQ091.USD","LU2471134523.USD","LU2237443465.HKD","IE0004445239.USD","LU0203202063.USD","IE00BWXC8680.SGD","LU2168564495.EUR","LU0094547139.USD","IE00BFSS8Q28.SGD","LU0385154629.USD","IE00BJJMRX11.SGD","LU0320765992.SGD","LU1127390331.HKD","LU2237443549.SGD","IE00BFSS7M15.SGD","LU2089284900.SGD","IE0001KFT4U8.USD","LU0234572021.USD","LU0198837287.USD","LU1988902786.USD","LU0225283273.USD","LU1069344957.HKD","LU2461242641.AUD","BK4581","LLII","LLY","LU0823434583.USD","NVO","IE00BK4W5L77.USD","LU0889565916.HKD","BK4532","LU1551013342.USD","LU0006306889.USD","LU0316494557.USD","LU2471134796.USD","LU2361044865.SGD","SGXZ57979304.SGD","LU2324357040.USD","LU2462157665.USD","LU0323591593.USD","LU1061106388.HKD","LU1868836757.USD","LU2087625088.SGD","LU2168564065.EUR","LU1366192091.USD","LU2236285917.USD","LU2357305700.SGD","LU0320765059.SGD","IE00BJT1NW94.SGD","LU0964807845.USD","LU1868836591.USD","LU1291159041.SGD","SG9999018857.SGD","BK4599","IE00B1BXHZ80.USD","LU1623119135.USD","IE00BFTCPJ56.SGD","LU0256863902.USD","LU1145028129.USD","SG9999015986.USD","LU2552382215.SGD","LU0353189680.USD","IE00BJJMRY28.SGD","LLYX","LU0122379950.USD","LU0348744763.USD","LU0823416689.USD","LU0210536198.USD","LU0787776722.HKD","LU1057294990.SGD","LU2361045086.USD","LU1868837300.USD","IE00B4R5TH58.HKD","LU2063271972.USD","IE00BN29S564.USD","LU0289739699.SGD","LU2271345857.HKD","NVOH","SGXZ31699556.SGD","LU1720051017.SGD","LU2417539215.USD","LU2237438978.USD","LU2491049909.HKD","IE00BKDWB100.SGD","LU0096364046.USD","LU1323610961.USD","LU0109394709.USD","LU2750360641.GBP","SG9999017495.SGD","LU1035775433.USD","LU2237443978.SGD","SG9999018865.SGD","LU1720051108.HKD","LU2602419157.SGD","SGXZ99366536.SGD","LU2213496289.HKD","LU2756315318.SGD","LU0203201768.USD","LU0114720955.EUR","LU2471134879.HKD","IE00BKVL7J92.USD","LU0154236417.USD","BK4596","LU2089283258.USD","LU1267930730.SGD","LU1023059063.AUD","LU1629891620.HKD","LU2360106947.USD","LU1093756325.SGD","IE00BK4W5M84.HKD","LU0109391861.USD","LU2746668461.USD","LU2756315664.SGD","LU0256863811.USD","SG9999015945.SGD","LU2361044949.HKD","IE00B2B36J28.USD","LU2237443382.USD","LU2491050071.SGD","SG9999015978.USD","LU2168564222.USD","LU0238689110.USD","SG9999014880.SGD","LU2746668974.SGD","IE00BJLML261.HKD","LU0882574139.USD","LU2896262040.SGD","LU0158827948.USD","LU2023251221.USD","LU1868837136.USD","LU0820562030.AUD","LU0943347566.SGD","IE00BJJMRZ35.SGD","LU1064131342.USD","SG9999013999.USD","SGXZ51526630.SGD","LU0708995401.HKD","BK4585","LU0106261372.USD","BK4007","BK4516","NVOX","LU1917777945.USD","LLYZ","LU0354030438.USD","LU0353189763.USD","LU1548497426.USD","GB00BDT5M118.USD","BK4523"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625053964","title":"巨头之战：礼来口服减肥药获批 诺和诺德抛出数据回应","url":"https://stock-news.laohu8.com/highlight/detail?id=2625053964","media":"21世纪经济报道","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625053964?lang=zh_cn&edition=full","pubTime":"2026-04-08 07:00","pubTimestamp":1775602800,"startTime":"0","endTime":"0","summary":"4月3日，就在礼来（EliLilly）宣布其口服小分子GLP-1药物Orforglipron（商品名：Foundayo）获得FDA（美国食品药品监督管理局）批准仅两天后，诺和诺德（NovoNordisk）迅速发起了反击。这家丹麦制药巨头宣布将在肥胖医学协会年会上公布ORION研究结果。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604083696939773.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604083696939773.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2237443895.HKD","NVO","BK4007","LU2552382132.HKD","LU1551013342.USD","SG9999014914.USD","IE00B4JS1V06.HKD","LU1551013425.SGD","SGXZ31699556.SGD","SG9999015945.SGD","LU2750360997.AUD","IE00B2B36J28.USD","LU2552382058.USD","LU1629891620.HKD","LU2028103732.USD","LU1232071149.USD","LU0689472784.USD","LU1988902786.USD","LU0079474960.USD","LU0640476718.USD","LU2087625088.SGD","LU2237443382.USD","IE00BN29S564.USD","LU2471134796.USD","IE00BJJMRY28.SGD","SG9999014898.SGD","IE00B4R5TH58.HKD","LU2089284900.SGD","LU0683600562.USD","LU0198837287.USD","LU2491049909.HKD","LU0354030438.USD","LU0471298694.HKD","LU2237438978.USD","LU0708995401.HKD","IE00BKVL7J92.USD","LU2462157665.USD","SG9999018865.SGD","LU0225283273.USD","LU2271345857.HKD","LU0456855351.SGD","LU0466842654.USD","LU0203201768.USD","LU2471134523.USD","LU0109394709.USD","LU1323610961.USD","LU0256863902.USD","LU2896262040.SGD","LLYX","LU1057294990.SGD","LU1868837300.USD","LU2168564222.USD","LU0882574139.USD","LU0823416689.USD","LU2417539215.USD","LU2602419157.SGD","LU0786609619.USD","IE00BWXC8680.SGD","LU0787776722.HKD","LU2236285917.USD","LU2111349929.HKD","LU2324357040.USD","IE00BJJMRX11.SGD","LU1069344957.HKD","LU0354030511.USD","LU1548497426.USD","IE00BJJMRZ35.SGD","SGXZ57979304.SGD","BK4588","LU1983299246.USD","LU2746668974.SGD","LU1989771016.USD","SGXZ99366536.SGD","LU0114720955.EUR","LU0106261372.USD","LU0882574055.USD","IE00BKDWB100.SGD","LU2750360641.GBP","LU1280957306.USD","IE0001KFT4U8.USD","LU0058720904.USD","LU0943347566.SGD","LU1093756168.USD","LU2213496289.HKD","IE00B775H168.HKD","LU2471134879.HKD","SG9999001176.SGD","LLY","IE00BFSS8Q28.SGD","LU1804176565.USD","LU1127390331.HKD","LU2237443978.SGD","LU0823434583.USD","LU2237443465.HKD","LU1868837136.USD","IE00B1XK9C88.USD","LU2491050154.USD","BK4599","SG9999015952.SGD","LU2491050071.SGD","LU1720051108.HKD","LU0210536198.USD","BK4533","IE00BZ1G4Q59.USD","LU0889565916.HKD","LU0234572021.USD","LU1712237335.SGD","LLII","LU0471298777.SGD","LU2237443622.USD","LU0256863811.USD","IE0004445015.USD","LU0823434740.USD","LU2168564149.EUR","LU2456880835.USD","BK4581","LU0203202063.USD","LU1267930730.SGD","LU2746668461.USD","BK4585","LU2168564065.EUR","LU1868836591.USD","IE00BK4W5L77.USD","LU0316494557.USD","SG9999013999.USD","IE00B1BXHZ80.USD","LU2112291526.USD","LU0096364046.USD","IE00BFTCPJ56.SGD","LU1623119135.USD","LU2168563687.JPY","LU0385154629.USD","IE00B7KXQ091.USD","LU2471134952.CNY","LU2089984988.USD","IE00BFSS7M15.SGD","GB00BDT5M118.USD","LU0238689110.USD","LU1061106388.HKD","LU2063271972.USD","SG9999015986.USD","LU0061475181.USD","IE0005OL40V9.USD","LU0672654240.SGD","LLYZ","LU1868836914.USD","LU2361044865.SGD","LU0820562030.AUD","SG9999015978.USD","LU2023250330.USD","LU1035775433.USD","LU2211815571.USD","LU2468319806.SGD","SG9999018857.SGD","NVOX","LU1917777945.USD","IE0002141913.USD","LU1145028129.USD","LU0006306889.USD","LU2756315664.SGD","IE0009355771.USD","BK4532","LU0109391861.USD","LU0320765059.SGD","LU0122379950.USD","LU1064131342.USD","SG9999014880.SGD","LU0417517546.SGD","LU2360106947.USD","LU1974910355.USD","LU1366192091.USD","LU0158827948.USD","LU2023251221.USD","LU1023059063.AUD","LU0353189763.USD","NVOH","LU2552382215.SGD","LU1720051017.SGD","ELIS","IE00BK4W5M84.HKD","LU2089283258.USD","IE00BKPKM429.USD","LU0353189680.USD","LU2023250504.SGD","LU0154236417.USD","SG9999017495.SGD","LU2264538146.SGD","IE00BJT1NW94.SGD","LU2361045086.USD","LU2756315318.SGD","SG9999001176.USD","LU0158827781.USD","LU2108987350.USD","LU2361044949.HKD","LU2168564495.EUR","LU0323591593.USD","BK4516","BK4534","LU1868836757.USD","ELIL","IE0004445239.USD","LU2237443549.SGD","LU0097036916.USD","LU0820561818.USD","LU1093756325.SGD","LU1291159041.SGD","LU2106854487.HKD","IE00BJLML261.HKD","LU0320765992.SGD","LU0820561909.HKD","SG9999014906.USD","LU0094547139.USD","LU1814569148.SGD","LU2357305700.SGD","LU0964807845.USD","LU0432979614.USD","SGXZ51526630.SGD","LU0289739699.SGD","LU2265009873.SGD","LU2461242641.AUD","LU0266013472.USD","SGXZ81514606.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625963748","title":"诺和诺德推出399美元Wegovy HD 比礼来竞品便宜约40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625963748","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625963748?lang=zh_cn&edition=full","pubTime":"2026-04-08 03:32","pubTimestamp":1775590377,"startTime":"0","endTime":"0","summary":"诺和诺德正以更积极的姿态推进定价策略和配方升级，以期重获肥胖药物市场的增长动力。该公司推出了更高剂量的Wegovy版本，其定价显著低于主要竞争对手。 诺和诺德表示，其新款Wegovy HD注射剂对自费患者的定价为每月399美元，比礼来旗下Zepbound最高三种剂量的收费低约40%。 此次推出也是诺和诺德通过新剂型和定价模式扩展其肥胖药物产品线的更广泛努力的一部分。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-08/doc-inhtthnr6857128.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["IE00B4JS1V06.HKD","LU2213496289.HKD","IE00B1BXHZ80.USD","LU2168564149.EUR","LU1064131342.USD","IE0005OL40V9.USD","LU0787776722.HKD","LU2211815571.USD","SG9999001176.USD","LU0385154629.USD","LU2023250330.USD","LU0098860793.USD","LU0868494617.USD","LU0882574055.USD","LU1093756325.SGD","SGXZ51526630.SGD","BK4585","LU1496350502.SGD","LU0786609619.USD","IE00BK4W5M84.HKD","LU0942090050.USD","LU1366192091.USD","LU0203202063.USD","LU1989772840.SGD","LU1267930730.SGD","LU2168564065.EUR","BK4083","LU0203201768.USD","LU2746668461.USD","IE0009355771.USD","LU2602419157.SGD","SG9999018865.SGD","LLYX","LU2111349929.HKD","LU2552382058.USD","NVO","SG9999017495.SGD","LU1280957306.USD","LU0320765059.SGD","LU1988902786.USD","LU1232071149.USD","LU2089984988.USD","BK4533","LU1929549753.HKD","LU2237443382.USD","LU0109391861.USD","LU2746668974.SGD","LU0225283273.USD","LU2089284900.SGD","IE00BK4W5L77.USD","SGXZ99366536.SGD","LU2237443978.SGD","SG9999001440.SGD","IE00BJJMRZ35.SGD","IE00BKVL7J92.USD","BK4534","IE00BFTCPJ56.SGD","LU0708995401.HKD","LU1236620750.USD","LU1868837300.USD","LU2471134952.CNY","IE00BN29S564.USD","SG9999014880.SGD","LU0238689110.USD","LU1674673691.USD","LU2023250504.SGD","LU2168564495.EUR","LU0289739699.SGD","LU2491050154.USD","IE00B2B36J28.USD","LU2106854487.HKD","LU0683600562.USD","SGXZ81514606.USD","IE00BFSS8Q28.SGD","LU1551013342.USD","IE00BKPKM429.USD","LU1623119135.USD","LU1868836591.USD","LU0198837287.USD","LU1035775433.USD","LU0417517546.SGD","IE00BJJMRX11.SGD","LU1551013425.SGD","IE00BJJMRY28.SGD","IE00BJT1NW94.SGD","LU1674673428.USD","IE00B775H168.HKD","LU0061475181.USD","LU2461242641.AUD","LU2468319806.SGD","LU1057294990.SGD","LU1323610961.USD","LU1868836757.USD","LU0323591593.USD","IE00BSNM7G36.USD","NVOH","LU1069344957.HKD","LU2471134879.HKD","LU0354030438.USD","LU0640476718.USD","LU0672654240.SGD","IE0001KFT4U8.USD","IE00B7KXQ091.USD","LU1548497426.USD","LU0094547139.USD","LU2264538146.SGD","NVOX","IE0004445239.USD","LU1989772923.USD","LU2237443465.HKD","LU2552382215.SGD","LU2361044949.HKD","LU2108987350.USD","ELIL","LU2237443622.USD","LU0158827948.USD","LU0266013472.USD","LU0316494557.USD","LU2896262040.SGD","IE00BJLML261.HKD","LU0158827781.USD","LU0006306889.USD","LU2456880835.USD","SGXZ57979304.SGD","LU0109394709.USD","IE00BWXC8680.SGD","LU1814569148.SGD","LU2023251221.USD","LU0354030511.USD","LU2087625088.SGD","SG9999014906.USD","LU1496350171.SGD","LU0154236417.USD","LU0823416689.USD","LU1974910355.USD","LU2360106947.USD","LU2750360641.GBP","LU2265009873.SGD","LU0097036916.USD","LU0096364046.USD","LU0256863902.USD","LU1023059063.AUD","LU2491050071.SGD","SG9999013999.USD","LU0823434740.USD","LU1868836914.USD","LU2552382132.HKD","LU2236285917.USD","IE00B1XK9C88.USD","LU0943347566.SGD","LU1145028129.USD","LU1917777945.USD","LU0471298777.SGD","LU1989771016.USD","LU0114720955.EUR","LU0234572021.USD","GB00BDT5M118.USD","LU2750360997.AUD","LU2361045086.USD","BK4532","LU1162221912.USD","LU2271345857.HKD","SG9999014898.SGD","LU0820561818.USD","LU1868837136.USD","LU0320765646.SGD","LU2168563687.JPY","BK4581","IE0004445015.USD","LU0058720904.USD","LU0471298694.HKD","LU0882574139.USD","LU2471134523.USD","LU2417539215.USD","LU2491049909.HKD","LLII","BK4588","BK4504","LU0210536198.USD","LU2462157665.USD","SG9999014914.USD","BK4567","BK4007","IE00B4R5TH58.HKD","LU0889565916.HKD","IE00BKDWB100.SGD","LU1720051017.SGD","LU2361044865.SGD","LU1720051108.HKD","ELIS","LU0353189680.USD","LU2357305700.SGD","SG9999015978.USD","SG9999015986.USD","IE00BZ1G4Q59.USD","LU1712237335.SGD","LU1236620834.HKD","LU1804176565.USD","LU0823434583.USD","IE0002141913.USD","LU1291159041.SGD","SG9999018857.SGD","SG9999015952.SGD","LU1914381329.SGD","LU0320765992.SGD","BK4550","LU2237443549.SGD","LU1061106388.HKD","LU1778281490.HKD","LU2756315664.SGD","LU0689472784.USD","LU2028103732.USD","LU0820561909.HKD","LU2324357040.USD","LU0466842654.USD","LU2237438978.USD","LU0868494708.USD","SGXZ31699556.SGD","BK4516","LU0106261372.USD","LU0353189763.USD","LU1093756168.USD","LU2112291526.USD","LU0079474960.USD","LU2237443895.HKD","SG9999001176.SGD","BK4566","LU0432979614.USD","LU1629891620.HKD","LU2168564222.USD","LLYZ","LU0823411888.USD","LLY","LU2471134796.USD","LU2089283258.USD","LU1127390331.HKD","IE00BFSS7M15.SGD","LU0964807845.USD","LU1983299246.USD","LU0456855351.SGD","LU2063271972.USD","BK4599","LU0256863811.USD","LU0820562030.AUD","LU2756315318.SGD","LU0122379950.USD","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625955272","title":"剂量翻三倍、月费仅涨50美元：诺和诺德(NVO.US)推高剂量Wegovy硬刚礼来(LLY.US)Zepbound","url":"https://stock-news.laohu8.com/highlight/detail?id=2625955272","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625955272?lang=zh_cn&edition=full","pubTime":"2026-04-07 21:30","pubTimestamp":1775568641,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺和诺德宣布，将面向自费患者，把新款高剂量减肥药Wegovy的价格定为每月399美元，这一定价低于其竞争对手礼来旗下Zepbound多数规格的售价。诺和诺德表示，高剂量版Wegovy将于本周二正式上市。此前一项临床试验显示，Zepbound在减重效果上优于标准剂量的Wegovy。诺和诺德寄希望于Wegovy新剂型实现业绩反弹。自费患者可通过诺和诺德直营消费者平台NovoCare、常规药房渠道及指定远程医疗合作方购买。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425602.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SG9999017495.SGD","BK4007","LU1127390331.HKD","LU2491050154.USD","LU0203202063.USD","IE00BJJMRX11.SGD","LU2468319806.SGD","SG9999014906.USD","IE00BWXC8680.SGD","LU2168564149.EUR","LU2602419157.SGD","BK4599","IE00BKVL7J92.USD","LU0061475181.USD","SGXZ51526630.SGD","LU0456855351.SGD","LU0640476718.USD","BK4532","LU0823434583.USD","LU1093756325.SGD","IE00B7KXQ091.USD","LU0823416689.USD","LU1989771016.USD","LU2023250504.SGD","LU0323591593.USD","LU0385154629.USD","LU1267930730.SGD","LU1323610961.USD","IE0005OL40V9.USD","LU2417539215.USD","LU1548497426.USD","LU1061106388.HKD","LU2265009873.SGD","LU0672654240.SGD","LU0158827781.USD","LU0889565916.HKD","IE00BFTCPJ56.SGD","SG9999018865.SGD","LU2236285917.USD","IE0001KFT4U8.USD","IE00BN29S564.USD","LU1868836757.USD","LU0058720904.USD","LU0820561818.USD","LU0109391861.USD","LU2089283258.USD","IE00B1BXHZ80.USD","LU1868836591.USD","LU2552382058.USD","BK4534","LU0234572021.USD","LU1623119135.USD","LU1291159041.SGD","LU2746668461.USD","LU2750360641.GBP","NVOX","LU0225283273.USD","LU1814569148.SGD","LU1035775433.USD","LU2471134796.USD","IE00BFSS8Q28.SGD","LU0256863902.USD","SG9999015986.USD","LU2471134523.USD","IE00BZ1G4Q59.USD","LU2168564495.EUR","IE00BJJMRY28.SGD","SG9999014914.USD","SGXZ31699556.SGD","IE0009355771.USD","LLY","LU0094547139.USD","LU0471298777.SGD","LU0823434740.USD","LU2756315664.SGD","LU2552382215.SGD","LU0238689110.USD","LU0106261372.USD","SGXZ81514606.USD","LU1366192091.USD","LU1232071149.USD","LU2357305700.SGD","LU2462157665.USD","IE00BKDWB100.SGD","LU2896262040.SGD","BK4516","LU0316494557.USD","LU1093756168.USD","LU2237443382.USD","LU2237443895.HKD","LU2491049909.HKD","IE0004445239.USD","LU2108987350.USD","LU0708995401.HKD","LU0158827948.USD","LU1720051108.HKD","LU1804176565.USD","LU1868837136.USD","LU2237443978.SGD","IE00BK4W5M84.HKD","LU0109394709.USD","LU0079474960.USD","LU2264538146.SGD","LU2746668974.SGD","SG9999013999.USD","LU2023251221.USD","LU1064131342.USD","LU0943347566.SGD","LU0210536198.USD","BK4588","LU1868836914.USD","SG9999015952.SGD","LU0289739699.SGD","SG9999014898.SGD","LU1868837300.USD","LU0964807845.USD","LU0154236417.USD","NVO","LU0097036916.USD","SG9999015978.USD","ELIS","LU0353189763.USD","IE00B1XK9C88.USD","LU0432979614.USD","IE00BJLML261.HKD","SG9999015945.SGD","BK4581","LLYZ","LU0354030438.USD","IE0004445015.USD","LU0353189680.USD","LU0787776722.HKD","LU0820562030.AUD","LU2168563687.JPY","IE00B775H168.HKD","SG9999014880.SGD","IE00BJT1NW94.SGD","LU0096364046.USD","LU1720051017.SGD","IE00BJJMRZ35.SGD","LU2213496289.HKD","IE00BK4W5L77.USD","LU2361045086.USD","LU2168564065.EUR","LU0689472784.USD","LU2106854487.HKD","LU2237443465.HKD","NVOH","LU2112291526.USD","LU0198837287.USD","LU2237443549.SGD","GB00BDT5M118.USD","IE00BKPKM429.USD","LU0354030511.USD","LU2271345857.HKD","LU0786609619.USD","LU2237438978.USD","IE00BFSS7M15.SGD","LU2324357040.USD","LU2552382132.HKD","LU1280957306.USD","LU2023250330.USD","LU0114720955.EUR","LLYX","LU1069344957.HKD","LU1551013342.USD","LU2089284900.SGD","BK4585","LU2456880835.USD","LU2461242641.AUD","LU2361044865.SGD","LU2756315318.SGD","SG9999018857.SGD","IE00B2B36J28.USD","LU2360106947.USD","LU2089984988.USD","LU2111349929.HKD","LU0320765992.SGD","LU1057294990.SGD","IE0002141913.USD","LU2087625088.SGD","LU0266013472.USD","LU0882574139.USD","LU0882574055.USD","LU1023059063.AUD","LU2211815571.USD","LU0471298694.HKD","LU0256863811.USD","LU0683600562.USD","LU0820561909.HKD","LU2063271972.USD","LU2237443622.USD","LU0203201768.USD","SGXZ99366536.SGD","LU1974910355.USD","LU1712237335.SGD","LU0466842654.USD","LU1629891620.HKD","ELIL","IE00B4R5TH58.HKD","LU2361044949.HKD","SGXZ57979304.SGD","BK4533","SG9999001176.USD","LU0122379950.USD","LU0417517546.SGD","SG9999001176.SGD","LU1983299246.USD","LU2491050071.SGD","LU0320765059.SGD","LLII","LU1917777945.USD","LU2168564222.USD","LU1551013425.SGD","LU2028103732.USD","LU1145028129.USD","LU2750360997.AUD","LU1988902786.USD","IE00B4JS1V06.HKD","LU2471134879.HKD","LU0006306889.USD","LU2471134952.CNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625677621","title":"诺和诺德首席执行官Mike Doustdar：减肥药需求远超行业目前所能提供的规模。","url":"https://stock-news.laohu8.com/highlight/detail?id=2625677621","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625677621?lang=zh_cn&edition=full","pubTime":"2026-04-06 22:55","pubTimestamp":1775487329,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["NVO","BK4532","IE00BKVL7J92.USD","LU1093756325.SGD","BK4588","BK4599","LU0154236417.USD","BK4585","LU1093756168.USD","NVOX","BK4007","IE00BZ1G4Q59.USD","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625677943","title":"诺和诺德：减肥药热潮远未达到顶峰","url":"https://stock-news.laohu8.com/highlight/detail?id=2625677943","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625677943?lang=zh_cn&edition=full","pubTime":"2026-04-06 22:53","pubTimestamp":1775487180,"startTime":"0","endTime":"0","summary":"诺和诺德公司指出了一个简单的事实：减肥药热潮远未达到顶峰。即使有Wegovy和Ozempic这样的重磅药物，以及来自礼来日益激烈的竞争，市场看起来仍然基本上未被开发。 这正开始改变诺和诺德对增长的思考方式。该公司正准备大幅下调美国市场的价格，预计从明年开始，Wegovy将降价约50%，Ozempic将降价约33%。礼来正在推进其自研的减肥药丸，而在司美格鲁肽失去 exclusivity 之后，仿制药已开始出现在印度和中国等市场。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-06/doc-inhtqsxv7722628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4599","BK4532","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","NVOX","NVOH","BK4007","LU0154236417.USD","NVO","BK4588","LU1093756168.USD","BK4585","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625627270","title":"司美格鲁肽口服减重药已开出超60万张处方 诺和诺德CEO：减重药市场目前仅触及“皮毛”","url":"https://stock-news.laohu8.com/highlight/detail?id=2625627270","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625627270?lang=zh_cn&edition=full","pubTime":"2026-04-06 15:15","pubTimestamp":1775459711,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LLY","BK4007","NVO","NVOH","BK4585","LU0154236417.USD","IE00BKVL7J92.USD","BK4532","BK4599","LU1093756325.SGD","NVOX","BK4588","IE00BZ1G4Q59.USD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625962091","title":"司美格鲁肽口服减重药已开出超60万张处方，市场空间还有多大","url":"https://stock-news.laohu8.com/highlight/detail?id=2625962091","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625962091?lang=zh_cn&edition=full","pubTime":"2026-04-06 15:05","pubTimestamp":1775459100,"startTime":"0","endTime":"0","summary":"由于投资人担心诺和诺德的司美格鲁肽减重药市场份额进一步下滑，今年至今，诺和诺德股价累计跌幅接近30%，目前市值不到1300亿美元。晨星公司估计，到2034年，口服减重药可能占据1800亿美元的全球减重药市场规模的约三分之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-04-06/doc-inhtpvua4544996.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-04-06/doc-inhtpvua4544996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NVOX","IE0034235071.USD","LU1863844665.USD","BK4532","NVO","BK4588","LU3187612489.SGD","NVOH","LU1829250122.USD","LLY","LU1863844749.USD","BK4585","IE00BZ1G4Q59.USD","BK4118","BK4534","BK4007","LU1093756168.USD","LU1093756325.SGD","LU0154236417.USD","IE00BKVL7J92.USD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624540736","title":"巨头之战：礼来口服减肥药获批，诺和诺德抛出数据回应","url":"https://stock-news.laohu8.com/highlight/detail?id=2624540736","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624540736?lang=zh_cn&edition=full","pubTime":"2026-04-03 19:00","pubTimestamp":1775214000,"startTime":"0","endTime":"0","summary":"4月3日，就在礼来（EliLilly）宣布其口服小分子GLP-1药物Orforglipron（商品名：Foundayo）获得FDA批准仅两天后，诺和诺德（NovoNordisk）迅速发起了反击。这家丹麦制药巨头宣布将在肥胖医学协会年会上公布ORION研究结果。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604033695090133.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604033695090133.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2468319806.SGD","LU0079474960.USD","LU2456880835.USD","LU2028103732.USD","IE00BKPKM429.USD","LU0061475181.USD","LU1267930730.SGD","LU2063271972.USD","LU2471134952.CNY","LU2602419157.SGD","SG9999015952.SGD","LU2361045086.USD","SG9999018865.SGD","IE00B4JS1V06.HKD","IE00BFTCPJ56.SGD","LU2089284900.SGD","LU0432979614.USD","LU1917777945.USD","LU0889565916.HKD","LU1069344957.HKD","IE00BWXC8680.SGD","LU2237443978.SGD","LU2168563687.JPY","LU2491049909.HKD","SGXZ81514606.USD","SGXZ31699556.SGD","NVOX","LU1366192091.USD","LU2361044949.HKD","LU1868836591.USD","LU2471134796.USD","LU0882574139.USD","LU1061106388.HKD","LLY","SG9999017495.SGD","LU0225283273.USD","LU0203201768.USD","LLYX","LU2417539215.USD","NVOH","BK4581","SG9999014880.SGD","LU0158827948.USD","IE00B775H168.HKD","LU0122379950.USD","LU2168564149.EUR","IE00BZ1G4Q59.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","IE00BJLML261.HKD","LU1720051108.HKD","LU0943347566.SGD","LU2265009873.SGD","LU1127390331.HKD","LU1023059063.AUD","LU2237443382.USD","LU2108987350.USD","LU0787776722.HKD","LU2237443622.USD","LU2462157665.USD","SGXZ99366536.SGD","SG9999014906.USD","IE0005OL40V9.USD","LU2271345857.HKD","IE00B4R5TH58.HKD","LU0094547139.USD","LU1280957306.USD","BK4588","LU2213496289.HKD","IE0004445239.USD","LU0289739699.SGD","LU2089984988.USD","LU0689472784.USD","LU2357305700.SGD","LU0320765992.SGD","IE0009355771.USD","LU0823416689.USD","LU1035775433.USD","LU0354030438.USD","SG9999018857.SGD","BK4532","LU0323591593.USD","LU0823434740.USD","LU2089283258.USD","LU1551013425.SGD","LU0154236417.USD","SG9999001176.SGD","ELIL","SG9999015945.SGD","LU0058720904.USD","LU2756315664.SGD","LU0820561909.HKD","LU0417517546.SGD","ELIS","LU2168564065.EUR","LU0109394709.USD","LU2211815571.USD","LU0708995401.HKD","LU0266013472.USD","IE00BFSS7M15.SGD","IE00BJJMRX11.SGD","LU1093756168.USD","LU2023250330.USD","IE00BJT1NW94.SGD","LU0471298777.SGD","IE00B2B36J28.USD","LU2106854487.HKD","LU2471134523.USD","SG9999013999.USD","LU2237438978.USD","IE0004445015.USD","LU2023251221.USD","IE00BKVL7J92.USD","LU0316494557.USD","LU0471298694.HKD","LU0320765059.SGD","LU2750360641.GBP","LU0198837287.USD","LU2168564222.USD","SG9999014898.SGD","LU0097036916.USD","IE00B1BXHZ80.USD","LU1720051017.SGD","LU2552382215.SGD","IE00BKDWB100.SGD","LU0353189763.USD","LU2168564495.EUR","LU0256863811.USD","LU2111349929.HKD","LU1989771016.USD","BK4007","LU0006306889.USD","LU1868837136.USD","LU2361044865.SGD","LU0882574055.USD","LU1983299246.USD","LU0238689110.USD","BK4533","LU2237443895.HKD","LU0466842654.USD","LU0353189680.USD","IE00BJJMRY28.SGD","LU1145028129.USD","LU1232071149.USD","IE00B1XK9C88.USD","LU1868836757.USD","LU1988902786.USD","LU0820562030.AUD","LU1323610961.USD","LU2324357040.USD","BK4585","GB00BDT5M118.USD","LU1548497426.USD","LU2750360997.AUD","BK4534","LU0096364046.USD","LU0256863902.USD","LU0672654240.SGD","LU2756315318.SGD","LU2552382058.USD","IE00B7KXQ091.USD","LU0106261372.USD","LU2746668461.USD","LU0456855351.SGD","LU1623119135.USD","LU1064131342.USD","LU0158827781.USD","LU0964807845.USD","LU1629891620.HKD","LU2237443465.HKD","LU2461242641.AUD","LU2491050154.USD","SG9999014914.USD","LU2237443549.SGD","SGXZ57979304.SGD","LU0823434583.USD","LU0109391861.USD","LU2236285917.USD","SG9999001176.USD","LU1712237335.SGD","LU1868836914.USD","BK4599","LU0210536198.USD","IE00BFSS8Q28.SGD","LU2471134879.HKD","LU1974910355.USD","BK4516","IE00BK4W5L77.USD","LU0114720955.EUR","LU2491050071.SGD","LU1868837300.USD","LU1814569148.SGD","LU1804176565.USD","IE00BK4W5M84.HKD","IE0001KFT4U8.USD","LU2087625088.SGD","LU2552382132.HKD","LU1291159041.SGD","SG9999015986.USD","LU0640476718.USD","LU2264538146.SGD","SGXZ51526630.SGD","LU2360106947.USD","LU0203202063.USD","LU0385154629.USD","LU0786609619.USD","LU2023250504.SGD","LU0234572021.USD","LU0683600562.USD","LU1093756325.SGD","LLII","LU0354030511.USD","NVO","LU1057294990.SGD","IE00BN29S564.USD","LU1551013342.USD","LU2746668974.SGD","LU2112291526.USD","SG9999015978.USD","LU2896262040.SGD","LU0820561818.USD","LLYZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624504856","title":"诺和诺德：Wegovy口服片剂表现优于礼来的口服GLP-1药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2624504856","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624504856?lang=zh_cn&edition=full","pubTime":"2026-04-02 21:18","pubTimestamp":1775135925,"startTime":"0","endTime":"0","summary":"表现出更明显的减重效果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624501755","title":"诺和诺德称：口服版Wegovy减肥效果优于礼来GLP‑1口服药","url":"https://stock-news.laohu8.com/highlight/detail?id=2624501755","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624501755?lang=zh_cn&edition=full","pubTime":"2026-04-02 21:02","pubTimestamp":1775134920,"startTime":"0","endTime":"0","summary":"诺和诺德周四表示，口服版 Wegovy 的平均减重效果显著优于礼来本周刚获批的竞品药物 Foundayo。诺和诺德称，另一项分析显示，84% 的患者更偏好与 Wegovy 相似的药物特性，而非 Foundayo。 此前研究显示，口服 Wegovy 平均减重幅度达16.6%；而坚持完成疗程的患者服用 Foundayo 后，平均减重约12.4%。 自 1 月初口服 Wegovy 在美国上市以来，处方量飙升，已有超 60 万名患者开始服用。 诺和诺德周四称，最新研究结果表明，口服 Wegovy 具备差异化竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-02/doc-inhtcnfs0874567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2491049909.HKD","LU2213496289.HKD","LU0058720904.USD","LU0964807845.USD","IE00BWXC8680.SGD","LU2552382058.USD","LU2552382215.SGD","IE00BFSS8Q28.SGD","LU0787776722.HKD","LU2023251221.USD","SG9999013999.USD","LU0203201768.USD","SG9999015952.SGD","LU2360106947.USD","SG9999014880.SGD","LU0820562030.AUD","LU0256863902.USD","LU2756315318.SGD","GB00BDT5M118.USD","LU1366192091.USD","IE0004445015.USD","IE00B1XK9C88.USD","IE0002141913.USD","LU0353189763.USD","LU0417517546.SGD","BK4533","LU0708995401.HKD","LU2552382132.HKD","SG9999001176.USD","SGXZ99366536.SGD","LU0889565916.HKD","LU0109391861.USD","SGXZ51526630.SGD","IE0005OL40V9.USD","LU0823416689.USD","LU1280957306.USD","NVOH","LU2168564149.EUR","LU1232071149.USD","LU0683600562.USD","LU2602419157.SGD","LU1093756325.SGD","LU0882574055.USD","IE00BZ1G4Q59.USD","LU1629891620.HKD","LU2237443895.HKD","LLY","BK4588","SG9999014914.USD","LU2112291526.USD","LU2237438978.USD","LU2236285917.USD","LLYX","IE00B2B36J28.USD","LU0158827948.USD","SG9999015978.USD","LU0096364046.USD","LU2471134796.USD","LU2468319806.SGD","LU1917777945.USD","LU0471298694.HKD","IE0001KFT4U8.USD","LU0198837287.USD","LU2746668461.USD","LU2491050154.USD","LU2746668974.SGD","LU2756315664.SGD","LU2461242641.AUD","LU0238689110.USD","LU2471134523.USD","LU1145028129.USD","LU0109394709.USD","LU1989771016.USD","BK4599","SG9999017495.SGD","LU2168563687.JPY","SGXZ57979304.SGD","LU2089283258.USD","BK4590","LLYZ","SG9999001176.SGD","LU1974910355.USD","LU0689472784.USD","LU1814569148.SGD","LU0106261372.USD","LU0203202063.USD","LU1035775433.USD","IE00BJJMRY28.SGD","LU1983299246.USD","LU0097036916.USD","LU2471134952.CNY","LU0094547139.USD","LU2023250330.USD","LU1868837136.USD","LU2237443622.USD","LU2106854487.HKD","LU1548497426.USD","BK4516","LU2211815571.USD","LU0225283273.USD","IE00BFSS7M15.SGD","LU0466842654.USD","IE00BK4W5M84.HKD","LU0432979614.USD","IE0004445239.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","LU1323610961.USD","LU1988902786.USD","LU0234572021.USD","IE0009355771.USD","LU2896262040.SGD","BK4532","LU1551013342.USD","LU0823434583.USD","LU2357305700.SGD","LU2087625088.SGD","LU0158827781.USD","SG9999014906.USD","LU1267930730.SGD","LU0823434740.USD","LU1623119135.USD","IE00BJT1NW94.SGD","LU1023059063.AUD","LU0385154629.USD","LU0266013472.USD","LU1868836757.USD","LU0456855351.SGD","LU0154236417.USD","LU0820561818.USD","LU2168564495.EUR","LU0114720955.EUR","LU0316494557.USD","LU2237443978.SGD","LU2491050071.SGD","LU0061475181.USD","LU2456880835.USD","ELIL","BK4534","IE00B7KXQ091.USD","LLII","LU2108987350.USD","LU0079474960.USD","NVOX","LU2750360641.GBP","LU2324357040.USD","NVO","LU1868836914.USD","IE00BN29S564.USD","LU0353189680.USD","LU0882574139.USD","LU1868836591.USD","IE00BKVL7J92.USD","LU1804176565.USD","SG9999014898.SGD","LU1868837300.USD","LU0256863811.USD","LU1069344957.HKD","LU2265009873.SGD","LU1127390331.HKD","LU2237443549.SGD","LU2237443465.HKD","LU1712237335.SGD","LU1057294990.SGD","LU2361045086.USD","LU1720051017.SGD","IE00BKDWB100.SGD","LU2462157665.USD","LU2750360997.AUD","LU1720051108.HKD","LU2417539215.USD","LU1093756168.USD","LU0006306889.USD","LU0672654240.SGD","BK4581","LU0122379950.USD","SG9999015986.USD","SGXZ81514606.USD","LU0820561909.HKD","LU0471298777.SGD","LU0354030438.USD","LU1291159041.SGD","LU1551013425.SGD","IE00B1BXHZ80.USD","LU0323591593.USD","IE00B775H168.HKD","LU0354030511.USD","IE00BKPKM429.USD","LU2063271972.USD","IE00BK4W5L77.USD","BK4007","LU2089284900.SGD","SGXZ31699556.SGD","LU2471134879.HKD","LU2264538146.SGD","IE00BJJMRX11.SGD","LU2028103732.USD","LU2271345857.HKD","ELIS","BK4144","LU0320765992.SGD","LU2361044865.SGD","LU0943347566.SGD","LU2361044949.HKD","SG9999018857.SGD","LU2023250504.SGD","IE00B4R5TH58.HKD","LU0786609619.USD","LU2089984988.USD","LU2237443382.USD","IE00B4JS1V06.HKD","LU2168564065.EUR","LU0320765059.SGD","LU0210536198.USD","SG9999015945.SGD","LU1064131342.USD","IE00BJLML261.HKD","SG9999018865.SGD","LU2111349929.HKD","LU0640476718.USD","IE00BJJMRZ35.SGD","LU2168564222.USD","LU0289739699.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156657448","title":"消息称特朗普拟对部分制药企业征收新关税","url":"https://stock-news.laohu8.com/highlight/detail?id=1156657448","media":"老虎资讯综合","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156657448?lang=zh_cn&edition=full","pubTime":"2026-04-02 07:45","pubTimestamp":1775087120,"startTime":"0","endTime":"0","summary":"某些药物和疾病类别也可能获得豁免。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"558a26cfa5754234b2e7f202aad8ac05","theme_name":"热榜No.14 · 特朗普最新动态","theme_type":2,"isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO","LLY","PFE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624510807","title":"礼来口服减肥药获批 加剧与诺和诺德竞争","url":"https://stock-news.laohu8.com/highlight/detail?id=2624510807","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624510807?lang=zh_cn&edition=full","pubTime":"2026-04-01 23:54","pubTimestamp":1775058899,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ce4b7877932b5a888416bb320979bf5f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2471134952.CNY","LU2237443549.SGD","LU1093756168.USD","IE00BJJMRX11.SGD","LU1267930730.SGD","LU2602419157.SGD","LU0006306889.USD","IE00B4R5TH58.HKD","LU2087625088.SGD","LU2236285917.USD","BK4585","LU1720051017.SGD","LU2896262040.SGD","LU0061475181.USD","SGXZ51526630.SGD","IE00BFTCPJ56.SGD","LU0225283273.USD","LU2491050071.SGD","SG9999014914.USD","LU2456880835.USD","LU1548497426.USD","LU2089284900.SGD","LU0385154629.USD","LU0456855351.SGD","IE0001KFT4U8.USD","LU0320765992.SGD","LU2106854487.HKD","SG9999014880.SGD","BK4599","LU0234572021.USD","LU1868836914.USD","LU2168563687.JPY","SG9999013999.USD","IE00B2B36J28.USD","LU1551013342.USD","LU1917777945.USD","IE00BJLML261.HKD","LU0323591593.USD","BK4533","SG9999018857.SGD","LU0158827781.USD","LU1868837300.USD","LU2264538146.SGD","LU2168564065.EUR","IE00BZ1G4Q59.USD","LU2462157665.USD","LU0820561909.HKD","LU0683600562.USD","LU0820562030.AUD","LU1280957306.USD","LU0672654240.SGD","LU2552382215.SGD","LU0823434583.USD","LU0708995401.HKD","LU2471134879.HKD","IE00BJJMRZ35.SGD","LU2112291526.USD","LU0238689110.USD","LU1551013425.SGD","SG9999018865.SGD","LU2237443465.HKD","LU0787776722.HKD","LU1232071149.USD","LU0289739699.SGD","LU1974910355.USD","LU2746668974.SGD","LU2360106947.USD","SG9999015945.SGD","LU0320765059.SGD","LU2028103732.USD","BK4532","LU1064131342.USD","LU1323610961.USD","GB00BDT5M118.USD","LU1057294990.SGD","IE00BJJMRY28.SGD","LU0109391861.USD","LU1814569148.SGD","LU1868836757.USD","SG9999014898.SGD","LU2168564495.EUR","LU2213496289.HKD","LU1127390331.HKD","LU2357305700.SGD","LU0266013472.USD","LU0058720904.USD","LU2237443382.USD","IE0005OL40V9.USD","LU1629891620.HKD","LU0256863902.USD","LU1988902786.USD","IE00BK4W5L77.USD","LU1712237335.SGD","LU0432979614.USD","LU0198837287.USD","LU0820561818.USD","LU2756315318.SGD","IE00B775H168.HKD","LU1983299246.USD","IE00BK4W5M84.HKD","LU0094547139.USD","LU0316494557.USD","LLII","LU0889565916.HKD","LU0466842654.USD","ELIL","LU0471298777.SGD","LU0114720955.EUR","LU2461242641.AUD","LU1366192091.USD","BK4588","LU0079474960.USD","LU2023251221.USD","SG9999015952.SGD","LU2089283258.USD","LU2237438978.USD","LU2471134523.USD","LU2168564149.EUR","LU2271345857.HKD","LU0256863811.USD","LU0689472784.USD","LU1804176565.USD","LU2750360997.AUD","SG9999001176.USD","LU2750360641.GBP","LU0203201768.USD","BK4581","NVOX","IE00B4JS1V06.HKD","LU2237443978.SGD","LU1291159041.SGD","IE00BKPKM429.USD","IE00BWXC8680.SGD","SG9999015986.USD","IE00B1BXHZ80.USD","SGXZ81514606.USD","IE00BFSS8Q28.SGD","LU1023059063.AUD","LU2491050154.USD","LU2468319806.SGD","LU0106261372.USD","LU0471298694.HKD","LU0096364046.USD","LU0210536198.USD","LU2361045086.USD","LU2491049909.HKD","SGXZ31699556.SGD","LU2552382132.HKD","LU1989771016.USD","LU0417517546.SGD","LU0109394709.USD","LU2324357040.USD","LU1093756325.SGD","LLYX","LLYZ","IE00BKDWB100.SGD","LLY","LU0354030511.USD","LU2417539215.USD","IE00BKVL7J92.USD","NVO","LU0354030438.USD","LU0882574055.USD","LU0964807845.USD","LU0097036916.USD","SG9999014906.USD","LU0353189763.USD","LU2756315664.SGD","LU0882574139.USD","LU2108987350.USD","ELIS","LU2023250504.SGD","LU0154236417.USD","BK4534","LU2265009873.SGD","LU2746668461.USD","LU2111349929.HKD","NVOH","LU2361044865.SGD","LU2361044949.HKD","LU1720051108.HKD","SG9999001176.SGD","BK4007","IE0002141913.USD","LU2237443622.USD","SGXZ57979304.SGD","IE00B1XK9C88.USD","LU0203202063.USD","LU0943347566.SGD","LU1145028129.USD","LU0823416689.USD","IE0004445239.USD","IE00B7KXQ091.USD","LU1623119135.USD","LU0122379950.USD","IE0004445015.USD","SG9999017495.SGD","LU2552382058.USD","LU1868836591.USD","BK4516","SGXZ99366536.SGD","LU0640476718.USD","LU0786609619.USD","LU0823434740.USD","LU2089984988.USD","LU0353189680.USD","IE00BFSS7M15.SGD","LU1069344957.HKD","SG9999015978.USD","IE00BJT1NW94.SGD","LU1061106388.HKD","LU2063271972.USD","LU2168564222.USD","IE0009355771.USD","LU2471134796.USD","IE00BN29S564.USD","LU2237443895.HKD","LU1035775433.USD","LU1868837136.USD","LU2023250330.USD","LU0158827948.USD","LU2211815571.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623860535","title":"诺和诺德(NVO)推出Wegovy折扣订阅计划 旨在降价抢攻减肥药市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2623860535","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623860535?lang=zh_cn&edition=full","pubTime":"2026-03-31 19:53","pubTimestamp":1774957981,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺和诺德宣布，将为美国自费患者推出减肥药 Wegovy 折扣订阅计划，自周二起通过多家远程医疗平台上线，后续还将接入更多合作方。该计划按月固定收费，可选 3 至 12 个月疗程，期限越长折扣越大，自费价格较标准价低近三成，最高可节省每年1200美元。此举旨在提升药物可及性，在肥胖症药物市场争夺份额。不过市场观点认为，诺和诺德降价幅度大于礼来，或在价格竞争中处于不利地位。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"298592","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJLML261.HKD","LU1804176565.USD","LU2552382058.USD","LU0787776722.HKD","LLYZ","LU2896262040.SGD","IE00BJJMRZ35.SGD","LU2089284900.SGD","LU0786609619.USD","SG9999014880.SGD","LU1868836914.USD","LU0823434583.USD","LU1093756168.USD","IE00BKVL7J92.USD","BK4585","LU1868836757.USD","LU2237438978.USD","LU0708995401.HKD","LU2756315664.SGD","LU0385154629.USD","LU0320765992.SGD","LU1712237335.SGD","LU2360106947.USD","LU1232071149.USD","LU0109391861.USD","SGXZ51526630.SGD","LU0354030511.USD","LU2236285917.USD","SG9999014906.USD","IE00BKDWB100.SGD","LU0058720904.USD","ELIS","LU0823416689.USD","LU2237443978.SGD","LU0266013472.USD","LU2461242641.AUD","LU2746668461.USD","LU1035775433.USD","LU2237443382.USD","LU2023250504.SGD","LU2552382132.HKD","LU1983299246.USD","LU0320765059.SGD","NVO","IE0004445239.USD","LU1057294990.SGD","SG9999015945.SGD","IE00B4R5TH58.HKD","LU2468319806.SGD","LLYX","LU0882574139.USD","LU1868837136.USD","BK4588","SG9999018857.SGD","LU0353189680.USD","LU1323610961.USD","LU2168564495.EUR","LU2237443622.USD","BK4007","LU0109394709.USD","LU0061475181.USD","LU2237443465.HKD","IE00B1XK9C88.USD","LU0114720955.EUR","LU2111349929.HKD","LU1720051108.HKD","SG9999015978.USD","SGXZ57979304.SGD","LU2089984988.USD","LU2471134952.CNY","SGXZ31699556.SGD","LU0006306889.USD","LU0640476718.USD","IE00B1BXHZ80.USD","LU2361044949.HKD","LU1974910355.USD","LU2264538146.SGD","LU2087625088.SGD","IE0002141913.USD","IE00B7KXQ091.USD","LU1069344957.HKD","IE00BK4W5M84.HKD","LU0323591593.USD","IE00BN29S564.USD","LU1548497426.USD","LU2089283258.USD","IE00BJJMRX11.SGD","BK4581","LU0210536198.USD","LU0256863902.USD","LU1061106388.HKD","LU0289739699.SGD","LU0820561909.HKD","LU1917777945.USD","LU2491050071.SGD","LU2746668974.SGD","LU0097036916.USD","LU0238689110.USD","LU1814569148.SGD","LU2324357040.USD","LU2028103732.USD","LU2471134879.HKD","LU2063271972.USD","LU0964807845.USD","LU0234572021.USD","LU1551013342.USD","LU0354030438.USD","SG9999001176.USD","IE00BJJMRY28.SGD","LU1629891620.HKD","BK4532","LU2417539215.USD","LLII","LU2361044865.SGD","LU2602419157.SGD","SG9999001176.SGD","LU2361045086.USD","SG9999014914.USD","LU0456855351.SGD","LU2168564149.EUR","IE00B4JS1V06.HKD","IE00BJT1NW94.SGD","SGXZ99366536.SGD","LU0672654240.SGD","LU1868836591.USD","LU1291159041.SGD","LU1720051017.SGD","LU1988902786.USD","LU0158827781.USD","LU1023059063.AUD","LU2108987350.USD","LU2168564222.USD","LU2471134523.USD","LU2271345857.HKD","LU0225283273.USD","IE0001KFT4U8.USD","LU2456880835.USD","IE00BZ1G4Q59.USD","LU2237443895.HKD","LU0203201768.USD","BK4533","LU0882574055.USD","LU1551013425.SGD","IE00BFSS7M15.SGD","IE00BK4W5L77.USD","LU2265009873.SGD","GB00BDT5M118.USD","LU1868837300.USD","LU1145028129.USD","LU0198837287.USD","LU0471298777.SGD","BK4516","LU2750360641.GBP","IE0005OL40V9.USD","SG9999013999.USD","LU0417517546.SGD","LU1623119135.USD","LU0889565916.HKD","LU2023251221.USD","LU2552382215.SGD","LU0943347566.SGD","IE00BFTCPJ56.SGD","LU0432979614.USD","BK4599","LU1127390331.HKD","LU2357305700.SGD","IE00BKPKM429.USD","LU2491050154.USD","LU1366192091.USD","LU1280957306.USD","LU0823434740.USD","LU0256863811.USD","LU0471298694.HKD","LU0106261372.USD","LU0154236417.USD","LU2462157665.USD","SG9999018865.SGD","IE0009355771.USD","LU0203202063.USD","LU0316494557.USD","SG9999014898.SGD","SG9999017495.SGD","LU1093756325.SGD","LU2491049909.HKD","IE00BWXC8680.SGD","LU1989771016.USD","LU0094547139.USD","LU2106854487.HKD","LU0683600562.USD","SGXZ81514606.USD","LU1267930730.SGD","LU2213496289.HKD","LU2211815571.USD","LU1064131342.USD","LU2471134796.USD","LU0353189763.USD","LU2168564065.EUR","IE00B2B36J28.USD","LU2168563687.JPY","IE0004445015.USD","LU0689472784.USD","LU0079474960.USD","SG9999015952.SGD","LU0096364046.USD","NVOH","LU0820562030.AUD","NVOX","ELIL","SG9999015986.USD","LU0122379950.USD","IE00BFSS8Q28.SGD","LU2750360997.AUD","LU0820561818.USD","LU0158827948.USD","LU0466842654.USD","LU2112291526.USD","BK4534","LU2756315318.SGD","LU2023250330.USD","LU2237443549.SGD","IE00B775H168.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136041471","title":"诺和诺德：Wegovy订阅计划将于3月31日起通过Ro、WeightWatchers和LifeMD提供","url":"https://stock-news.laohu8.com/highlight/detail?id=1136041471","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136041471?lang=zh_cn&edition=full","pubTime":"2026-03-31 19:34","pubTimestamp":1774956843,"startTime":"0","endTime":"0","summary":"诺和诺德公司宣布，其备受关注的减肥药物Wegovy订阅服务将从3月31日起正式上线。该计划将通过数字健康平台Ro、体重管理服务商WeightWatchers以及远程医疗提供商LifeMD向用户开放。\n这一举措标志着诺和诺德在拓宽Wegovy可及性方面迈出重要一步。通过与合作方联手，患者将能更便捷地获得这款GLP-1受体激动剂药物的专业指导和支持服务。\n订阅计划的推出正值减肥药物市场需求激增之际。分析认为，这种创新服务模式有望帮助更多肥胖症患者获得规范治疗，同时强化诺和诺德在代谢疾病领域的市场地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ea115adc665c74e6a4a5582f9333b9fe","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIMZ","NVO","HMYY","HIYY","HIMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111906858","title":"诺和诺德：Wegovy口服药9毫克及25毫克剂量推出订阅计划，3个月套餐每月289美元、6个月套餐每月269美元、12个月套餐每月249美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111906858","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111906858?lang=zh_cn&edition=full","pubTime":"2026-03-31 19:33","pubTimestamp":1774956827,"startTime":"0","endTime":"0","summary":"诺和诺德（Novo Nordisk）近日宣布，其备受关注的Wegovy口服药已推出灵活订阅方案，涵盖9毫克和25毫克两种剂量规格。用户现可选择3个月、6个月或12个月的不同订阅周期，享受阶梯式价格优惠：3个月套餐月费为289美元，6个月套餐月费降至269美元，而12个月长期订阅更可享每月249美元的超值价格。这一订阅模式旨在为长期体重管理需求者提供更可持续的经济选择，同时强化药物使用的连续性。随着Wegovy口服版本在减重市场的持续渗透，诺和诺德正通过多元化的支付策略进一步扩大其用户基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ea115adc665c74e6a4a5582f9333b9fe","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","BK4196","HIMZ","HIMY","NVO","HIYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622538856","title":"诺和诺德每周一次基础胰岛素制剂Awiqli获美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2622538856","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622538856?lang=zh_cn&edition=full","pubTime":"2026-03-28 14:06","pubTimestamp":1774678001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1093756325.SGD","BK4007","NVO","LU0154236417.USD","BK4599","LU1093756168.USD","BK4585","BK4532","BK4588","IE00BZ1G4Q59.USD","NVOH","NVOX","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622282640","title":"诺和诺德“周制剂”胰岛素获美国FDA批准上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2622282640","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622282640?lang=zh_cn&edition=full","pubTime":"2026-03-27 19:52","pubTimestamp":1774612372,"startTime":"0","endTime":"0","summary":"金吾财讯 | 诺和诺德宣布，美国食品药品监督管理局(FDA)正式批准其Awiqli(依柯胰岛素注射液:700单位/毫升)上市。该药物主要作为饮食和运动的辅助手段，旨在帮助改善成人2型糖尿病患者的血糖控制。该注射液获批上升后将把每周多达七次的常规基础胰岛素注射大幅缩减至仅需一次，为患者提供了一种革命性的替代方案。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210625/YzM0ZmE0OGYyYmI1ZTk0YjVmZmU4ZTU4MTIzMDA2MDU4MDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YzM0ZmE0OGYyYmI1ZTk0YjVmZmU4ZTU4MTIzMDA2MDU4MDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"298464","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","NVOH","LU1093756325.SGD","LU1093756168.USD","NVO","NVOX","IE00BKVL7J92.USD","BK4588","BK4007","BK4532","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622846972","title":"美股异动丨诺和诺德盘前涨超2%，“周制剂”胰岛素在美获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2622846972","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622846972?lang=zh_cn&edition=full","pubTime":"2026-03-27 16:09","pubTimestamp":1774598948,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["NVOX","IE00BZ1G4Q59.USD","LU0154236417.USD","NVOH","BK4532","LU1093756325.SGD","BK4599","NVO","BK4007","LU1093756168.USD","IE00BKVL7J92.USD","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novonordisk.com","stockEarnings":[{"period":"1week","weight":0.0124},{"period":"1month","weight":-0.0331},{"period":"3month","weight":-0.3634},{"period":"6month","weight":-0.3424},{"period":"1year","weight":-0.4248},{"period":"ytd","weight":-0.2642}],"compareEarnings":[{"period":"1week","weight":0.0367},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0204},{"period":"6month","weight":0.0412},{"period":"1year","weight":0.2393},{"period":"ytd","weight":-0.0029}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novo Nordisk A/S成立于1989年，由两家丹麦公司Nordisk Gentofte A/S和Novo Industri A/S合并而成。该公司是一家全球性的医疗保健公司，也是肥胖和糖尿病护理、制造和营销包括GLP-1受体激动剂和现代胰岛素在内的医药产品的世界领先企业。总部位于丹麦，业务遍及约80个国家，产品销往约170个国家。","yearOnYearQuotes":[{"month":1,"riseRate":0.533333,"avgChangeRate":0.120105},{"month":2,"riseRate":0.6,"avgChangeRate":0.019219},{"month":3,"riseRate":0.444444,"avgChangeRate":0.006415},{"month":4,"riseRate":0.622222,"avgChangeRate":0.015133},{"month":5,"riseRate":0.555556,"avgChangeRate":0.018382},{"month":6,"riseRate":0.688889,"avgChangeRate":0.026171},{"month":7,"riseRate":0.488889,"avgChangeRate":-0.001692},{"month":8,"riseRate":0.533333,"avgChangeRate":0.006145},{"month":9,"riseRate":0.555556,"avgChangeRate":-0.002979},{"month":10,"riseRate":0.488889,"avgChangeRate":-0.004606},{"month":11,"riseRate":0.6,"avgChangeRate":0.026574},{"month":12,"riseRate":0.733333,"avgChangeRate":0.048757}],"exchange":"NYSE","name":"诺和诺德","nameEN":"Novo-Nordisk A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺和诺德(NVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺和诺德,NVO,诺和诺德股票,诺和诺德股票老虎,诺和诺德股票老虎国际,诺和诺德行情,诺和诺德股票行情,诺和诺德股价,诺和诺德股市,诺和诺德股票价格,诺和诺德股票交易,诺和诺德股票购买,诺和诺德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺和诺德(NVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}